Logo

Charles River Labs Licenses Luminex s xMap Technology

Jan 06, 2006

NEW YORK, Dec. 6 (GenomeWeb News) - Charles River Labs has licensed Luminex's xMAP technology for use within its research models and services, the companies said yesterday.

 

Luminex's xMAP technology enables multiple assays to be performed in a single well using suspended beads.

Breaking News
The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.